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INTRODUCTION
The renin-angiotensin system (RAS) is a key regulator of blood pres-
sure and fluid homeostasis [1, 2]. The circulating angiotensinogen 
(AGT), produced by the liver, is cleaved by renin to yield angiotensin I, 
and further cleaved to angiotensin II by the angiotensin-converting 
enzyme (ACE). Angiotensin II is the major effector molecule of the 
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ABSTRACT: We aimed to replicate, in a specific athletic event cohort (only track and field) and in two different 
ethnicities (Japanese and East European, i.e. Russian and Polish), original findings showing the association of 
the angiotensin-II receptor type-2 gene (AGTR2) rs11091046 A>C polymorphism with athlete status. We 
compared genotypic frequencies of the AGTR2 rs11091046 polymorphism among 282 track and field sprint/
power athletes (200 men and 82 women), including several national record holders and Olympic medallists 
(214 Japanese, 68 Russian and Polish), and 2024 control subjects (842 men and 1182 women) (804 Japanese, 
1220 Russian and Polish). In men, a meta-analysis from the two combined cohorts showed a significantly higher 
frequency of the C allele in athletes than in controls (odds ratio: 1.62, P=0.008, heterogeneity index I 2=0%). 
With regard to respective cohorts, C allele frequency was higher in Japanese male athletes than in controls 
(67.7% vs. 55.9%, P=0.022), but not in Russian/Polish male athletes (61.9% vs. 51.0%, P=0.172). In women, 
no significant results were obtained by meta-analysis for the two cohorts combination (P=0.850). The AC 
genotype frequency was significantly higher in Russian/Polish women athletes than in controls (69.2% vs. 
42.1%, P=0.022), but not in Japanese women athletes (P=0.226). Our results, in contrast to previous findings, 
suggested by meta-analysis that the C allele of the AGTR2 rs11091046 polymorphism is associated with sprint/
power track and field athlete status in men, but not in women.
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RAS, acting via angiotensin II type 1 receptor (AGTR1) and type 2 
receptor (AGTR2), as a potent vasoconstrictor and muscle growth 
factor [2, 3, 4]. AGTR2 mediates the effects of angiotensin II on 
cellular differentiation and growth. It is generally reported to have 
opposite effects of those mediated by AGTR1, e.g. vasodilatation, 
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subjects (593 women) living in the Tokyo area. Athletes and controls 
belong to the same Eastern-Asian descent.
Russian/Polish cohort: Comprised 68 athletes (26 women): 
61 international; 7 national. The control group consisted of 1220 
healthy subjects (589 women) from Russia and Poland. Athletes and 
controls were all Caucasians of Eastern-European descent.
Genotyping
DNA samples were obtained from saliva, buccal swabs or venous 
blood and extracted as previously described [9-11]. For the Japanese 
cohorts, the AGTR2 rs11091046 polymorphism was genotyped at 
Juntendo University, Chiba, Japan, using a Real-Time Thermocycler 
in the end-point analysis mode (LightCycler 480, Roche Applied 
Science, Mannheim, Germany) with the TaqMan SNP genotyping 
assay method (Assay ID: C___1841568_10). Allelic discrimination 
analysis was performed with LightCycler 480 SW software version 
1.5.1.62 (Roche Applied Science, Mannheim, Germany). The Rus-
sian/Polish cohort was genotyped using allelic discrimination assays 
with TaqMan probes (Applied Biosystems, Carlsbad, California, USA) 
on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Her-
cules, California, USA) or by PCR on a Tercyk ‘multicanal amplifica-
tor’ (DNA Technology, Moscow, Russia) and restriction enzyme diges-
tion or by the use of HumanOmni1-Quad BeadChips (Illumina Inc, 
USA), as previously described [10].
Statistical analysis
The SPSS statistical package version 20.0 for Windows was used to 
perform all statistical evaluations. Intergroup genotype frequency 
differences were tested by Pearson’s χ2 test of independence. AGTR2 
rs11091046 is situated in the sexual X chromosome; males are 
hemizygous and contribute a single allele and females contribute two 
alleles to the genotype, and thus comparisons were made sepa-
rately by gender. Odds ratios (OR) and 95% confidence intervals (CI) 
were calculated to estimate the degree of contribution of the AGTR2 
rs11091046 polymorphism to athlete status. Meta-analysis was 
conducted using the Review Manager (RevMan) computer program 
(version 5.3; Copenhagen: The Nordic Cochrane Centre, The Cochrane 
Collaboration, http://tech.cochrane.org/revman). The DerSimonian 
and Laird random-effects models were used to calculate weighted 
OR of athletes with the C allele. The test of overall effect was assessed 
using the Z score. Heterogeneity, which assesses the consistency of 
the results of studies in meta-analyses, of OR between studies was 
assessed using the I2 statistic. The level of significance was set at 
P<0.05.
RESULTS 
Table 1 shows the genotype frequencies of the AGTR2 rs11091046 
polymorphism in the two ethnic groups. Meta-analysis showed that 
in the pooled model (Japanese + Russian/Polish populations), 
C allele frequency was significantly higher in male athletes (national 
and international) than in controls (OR: 1.62, 95% CI: 1.14-2.32; 
nitric oxide (NO) release and inhibition of proliferation and growth 
[2]. Two polymorphisms in the RAS genes, AGT Met235Thr (rs699) 
and ACE I/D (rs4340), have already been reported to be related to 
physical performance [5-9].
Mustafina et al. [10] recently found a novel genetic polymorphism 
in the RAS genes that seems to be a candidate explaining variabil-
ity in athletic performance phenotypes: an A>C polymorphism 
(rs11091046) in the AGTR2 gene of the X chromosome, located at 
Xq22-q23, has been shown to be associated with muscle fibre type 
composition in physically active Russian men, as well as with ath-
letic status and physical performance in Russian and Polish popula-
tions. The C allele of the AGTR2 rs11091046 polymorphism seems 
to be associated with a higher proportion of slow-twitch muscle fibres, 
endurance athlete status and aerobic performance; and the A allele 
seems to be associated with a higher percentage of fast-twitch fibres 
and power-oriented disciplines. Nevertheless, these results are not 
totally unequivocal since the C allele prevalence was also found to 
be higher in male strength athletes compared with control subjects. 
As no other information has been published on the association be-
tween the AGTR2 rs11091046 polymorphism and sprint/power 
performance, whether the Mustafina et al. results could be extrapo-
lated to other ethnicities remains to be elucidated. This is a question 
of interest because differences among the findings of studies in the 
field of genetics and athletic performance are partly attributable to 
the different sizes and ethnic/geographic origin of the study popula-
tions. Therefore, it is necessary to validate the aforementioned evi-
dence by replication in large, independent and event-specific cohorts 
of athletes from different ethnicities. To replicate the previous find-
ings, we compared genotypic frequencies of the AGTR2 rs11091046 
A>C polymorphism among Japanese, Russian and Polish sprint/
power track and field athletes and ethnically matched controls.
MATERIALS AND METHODS 
All athletes were sprint/power track and field competitors who par-
ticipated in sprint events up to 400 m, jumping events, and throw-
ing events. National athletes were defined as those who were com-
petitive at national level competitions in their respective country, 
while international athletes were defined as those who had com-
peted at major international competitions. All the participants were 
informed of the purpose and methods of the study, and each of them 
provided written informed consent for participation. The study was 
approved by ethics committees of Juntendo University, Nippon Sport 
Science University, and the National Institute of Health and Nutrition 
in Japan; and the ethics committees of St Petersburg University and 
the Pomeranian Medical University. This study was conducted, for 
each cohort, in accordance with the Declaration of Helsinki for Hu-
man Research.
Subjects
Japanese cohort: Consisted of 214 athletes (56 women): 42 inter-
national; 172 national. The control group consisted of 804 healthy 
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P=0.008) (see Figure 1), and in the same direction (although non-
significantly) in only male international athletes vs. controls (OR: 
1.52, 95% CI: 0.94-2.44; P=0.090 ). The C allele frequency was 
also significantly higher in Japanese male athletes than in controls 
(67.7% vs. 55.9%, OR: 1.65, 95% CI: 1.08 – 2.54, P=0.022), 
but not in the Russian/Polish population (OR: 1.56, 95% CI: 0.82-
2.96) (Table 1, Figure 1). In women, no significant results were found 
by meta-analysis (OR: 0.97, 95% CI: 0.70-1.34, P=0.850) 
(Figure 1). Nevertheless, the AC genotype frequency was signifi-
cantly higher in Russian/Polish women athletes than in controls 
(69.2% vs. 42.1%, P=0.022), but not in the Japanese population 
(P=0.226) (Table 1). No significant results were found comparing 
only international athletes in women.
DISCUSSION 
Our main finding was that the C allele of the AGTR2 rs11091046 
A>C polymorphism was more frequently distributed in sprint/power 
male athletes than in controls by meta-analysis presenting zero het-
erogeneity, in a relatively large cohort including two ethnic back-
grounds as well as in a Japanese population independently. How-
ever, no significant results were found by meta-analysis in women.
Mustafina et al. [10] previously reported that the C allele fre-
quency of the AGTR2 rs11091046 polymorphism was significantly 
higher in Russian and Polish endurance male and female athletes 
compared with power athletes and control subjects. Additionally, this 
allele was found to be associated with a higher proportion of slow-
twitch muscle fibres. Nevertheless, they also found that this C allele 
was more frequent in male strength athletes compared with controls, 
which is also in agreement with our findings in the present study, 
obtained by meta-analysis in two ethnicities. The contradiction found 
here with the previous study for AGTR2 rs11091046 C allele fre-
quency results in men could be explained by the wide range of sport 
disciplines included in the prior study, which complicated drawing 
firm conclusions. For this reason, we chose to improve in this study 
the specificity of our cohorts, restraining them to only track and field 
athletes. We also aimed to improve the competition level, including 
in our cohorts the best sprint/power athletes from every country, 
including several Olympic medallists and national record holders.
TABLE 1. Genotype/allele frequency distribution of the AGTR2 rs11091046 polymorphism, among the two ethnic cohorts. (Because 
AGTR2 is located on the X chromosome, men are hemizygous and contribute a single allele to the genotype).
Men   Alleles distribution  
    A   C χ2 P value 
Japanese Athletes (n=158) 51 (32.3%)   107 (67.7%) 0.022*
  Controls (n=211) 93 (44.1%)   118 (55.9%)  
Russian/Polish Athletes (n=42) 16 (38.1%)   26 (61.9%) 0.172
  Controls (n=631) 309 (49.0%)   322 (51.0%)  
Women   Genotypes distribution  
    AA AC CC χ2 P value 
Japanese Athletes (n=56) 4 (7.1%) 31 (55.4%) 21 (37.5%) 0.226
  Controls (n=593) 81 (13.7%) 268 (45.2%) 244 (41.1%)  
Russian/Polish Athletes (n=26) 4 (15.4%) 18 (69.2%) 4 (15.4%) 0.022*
  Controls (n=589) 140 (23.8%) 248 (42.1%) 201 (34.1%)  
FIG. 1. Results of the meta-analysis on two ethnic cohorts for the 
association between the AGTR2 rs11091046 polymorphism and 
sprint/power athlete status. C allele frequency in controls was set 
as the reference (if OR>1, C allele frequency is higher in athletes). 
OR: odd ratio, CI: confidence interval.
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letes. Indeed, as we have already mentioned, AGTR2 being able to 
down regulate AGTR1 expression and function, which can be related 
to the regulation of muscle development and specialization [17, 20, 
21], we can hypothesize that an increasing level of AGTR2 due to 
the C allele polymorphism could lead to increased muscle mass and 
type II muscle fibre type composition. In their previous study, how-
ever, Mustafina et al. reported the opposite direction for type II 
muscle fibre type composition [10]. Nevertheless, in this study the 
authors only differentiated type I from type II muscle fibres without 
information about type IIa and IIx subgroups’ distribution, and it is 
well known that type IIa fibres are associated with both sprint and 
endurance performance. Therefore, further studies are necessary to 
draw a firm conclusion on this functional mechanism.
It must be kept in mind that elite athletic status is a complex trait 
resulting from the interaction of numerous phenotypes, involving the 
combined influence of several genetic variants, each with a significant 
contribution, as well as the complex interaction of genetic variants 
that explain individual variations in performance. Further research 
models in the field of sports genetics should thus account for the 
polygenic nature of sports related phenotypes. More replication stud-
ies are needed in order to specify the genetic combinations required 
to become an elite athlete and to improve athletic performance and 
in order to determine how these combinations can differ among 
ethnicities.
CONCLUSIONS 
In summary, the C allele of the AGTR2 rs11091046 A>C polymor-
phism was associated with sprint/power track and field athlete status 
in men, assessed by meta-analysis of athletes from two different 
ethnicities. However, further replication and functional studies are 
necessary to confirm these findings.
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In women, no significant results were found by meta-analysis of 
the two cohorts (Figure 1). Independently, the AC genotype fre-
quency was significantly higher in Russian/Polish athletes than in 
their corresponding controls (Table 1). These results might suggest 
that the C allele can be favourable for sprint/power performance in 
men, and unfavourable for women in Caucasian populations. The 
differences in results between men and women in the present study 
could be attributed to gender-specific differences existing in response 
to stimulation and inhibition of the RAS [12, 13]: differential balance 
in the pressor and depressor arms of the RAS using different pathways 
depending on sex, differences in expression levels of the RAS com-
ponents, as well as several interactions between RAS and sexual 
hormones [14]. Nevertheless, the results obtained in the present 
study in women are hard to interpret due to skewed X-chromosom-
al inactivation: the AGTR2 gene being located within the X chromo-
some, men are hemizygous and contribute a single allele to the 
genotype, while women contribute two alleles to the genotype, al-
though one of their X chromosomes is randomly inactivated [15, 16].
The AGTR2 receptor is one of the components of the RAS, where 
angiotensin II exerts its actions via AGTR1 and AGTR2. Angiotensin II, 
among several functions, exerts effects on muscle performance, 
e.g. a direct hypertrophic effect as a skeletal muscle growth factor, 
enhanced noradrenalin release from the nervous system, and in-
creased capillary density in skeletal muscle, and has already been 
shown to be associated with strength- and power-related sports [3, 7]. 
AGTR2 is generally reported to mediate effects opposing and coun-
terbalancing those mediated by AGTR1, which is involved in muscle 
development regulation, i.e., reducing muscle weight, amount of 
fibre, and type II fibre area [17].
The rs11091046 polymorphism we analysed is located within 
the 3′-untranslated region of AGTR2, at a microRNA-response-element 
position possibly corresponding to the hsa-miR-208a-5p and 
hsa-miR-208b-5p binding sites (98% context score), even though 
this polymorphic site is poorly conserved among vertebrates (Tar-
getScanHuman tool, http://www.targetscan.org/ http://www.tar-
getscan.org/). Van Rooij et al. [18, 19] found that miR-208a is 
encoded by intron 27 of the myosin heavy chain 6 gene (MYH6) in 
humans and that miR-208b is encoded by intron 31 of the myosin 
heavy chain 7 gene (MYH7) in mice. Using the DDBJ Blastn bioin-
formatics tool (DNA Data Bank of Japan, http://blast.ddbj.nig.ac.
jp/), we confirmed that has-miR-208b-5p is encoded in the same 
location of MYH7 in humans. Van Rooij et al. showed miR-208a as 
required for cardiomyocyte hypertrophy, fibrosis, and expression of 
MYH7 in response to stress and hypothyroidism in humans [18] and 
miR-208b to control muscle myosin content, myofibre identity, and 
muscle performance in mice [19]. Thus, we might suggest that 
AGTR2 gene products can be influenced partly by miR-208 a- and/
or b-5p, and that the C allele of the AGTR2 rs11091046 polymor-
phism in this region can reduce the miRNA/mRNA binding affinity, 
leading to an increased number of AGTR2 products playing a pos-
sible role in muscle performance, especially among elite sprint ath-
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